SE9900398L - Ny användning inom transplantationskirurgi - Google Patents

Ny användning inom transplantationskirurgi

Info

Publication number
SE9900398L
SE9900398L SE9900398A SE9900398A SE9900398L SE 9900398 L SE9900398 L SE 9900398L SE 9900398 A SE9900398 A SE 9900398A SE 9900398 A SE9900398 A SE 9900398A SE 9900398 L SE9900398 L SE 9900398L
Authority
SE
Sweden
Prior art keywords
transplantation
new use
transplant surgery
present
islets
Prior art date
Application number
SE9900398A
Other languages
Unknown language ( )
English (en)
Other versions
SE523817C2 (sv
SE9900398D0 (sv
Inventor
Olle Korsgren
William Bennet
Bo Nilsson
Rolf Larsson
Original Assignee
Corline Systems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corline Systems Ab filed Critical Corline Systems Ab
Priority to SE9900398A priority Critical patent/SE523817C2/sv
Publication of SE9900398D0 publication Critical patent/SE9900398D0/sv
Priority to AU28399/00A priority patent/AU769063B2/en
Priority to US09/890,936 priority patent/US7981873B1/en
Priority to EP00906843A priority patent/EP1171156B1/en
Priority to CA2361949A priority patent/CA2361949C/en
Priority to JP2000596956A priority patent/JP2003501346A/ja
Priority to DE60032346T priority patent/DE60032346T2/de
Priority to PCT/SE2000/000223 priority patent/WO2000045837A1/en
Priority to AT00906843T priority patent/ATE348149T1/de
Publication of SE9900398L publication Critical patent/SE9900398L/sv
Publication of SE523817C2 publication Critical patent/SE523817C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9900398A 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler SE523817C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
AT00906843T ATE348149T1 (de) 1999-02-05 2000-02-04 Isolated islets, comprising insulin producing cells, coated with heparin
CA2361949A CA2361949C (en) 1999-02-05 2000-02-04 Heparin, or heparin conjugate, islets of langerhans
US09/890,936 US7981873B1 (en) 1999-02-05 2000-02-04 Use within transplantation surgery
EP00906843A EP1171156B1 (en) 1999-02-05 2000-02-04 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin
AU28399/00A AU769063B2 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
JP2000596956A JP2003501346A (ja) 1999-02-05 2000-02-04 移植手術における新規な使用
DE60032346T DE60032346T2 (de) 1999-02-05 2000-02-04 Neue Verwendung in der Transplantationsschirugie
PCT/SE2000/000223 WO2000045837A1 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Publications (3)

Publication Number Publication Date
SE9900398D0 SE9900398D0 (sv) 1999-02-05
SE9900398L true SE9900398L (sv) 2000-08-06
SE523817C2 SE523817C2 (sv) 2004-05-18

Family

ID=20414376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Country Status (9)

Country Link
US (1) US7981873B1 (sv)
EP (1) EP1171156B1 (sv)
JP (1) JP2003501346A (sv)
AT (1) ATE348149T1 (sv)
AU (1) AU769063B2 (sv)
CA (1) CA2361949C (sv)
DE (1) DE60032346T2 (sv)
SE (1) SE523817C2 (sv)
WO (1) WO2000045837A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
WO2004084930A1 (en) * 2003-03-26 2004-10-07 Develogen Aktiengesellschaft Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
CA2612621C (en) * 2005-07-01 2014-11-18 Corline Systems Ab Heparin coating of biological tissue
SE530716C2 (sv) 2006-10-06 2008-08-19 Corline Systems Ab Molekylärt aggregat på ett substrat
EP2550004A4 (en) * 2010-03-12 2014-07-02 Univ Australian HEPARANSULFATERSATZTHERAPIE
US9795629B2 (en) 2011-12-22 2017-10-24 Corline Systems Ab Aqueous solution comprising a macromolecular conjugate of heparin for the treatment of blood vessels
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation
CN120957766A (zh) 2023-03-30 2025-11-14 科林生物医学公司 肝素官能化表面及其制备和用途
EP4688028A1 (en) 2023-03-30 2026-02-11 Corline Biomedical AB A method for providing an improved heparin functionalized surface

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135916A (en) 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
DE495852T1 (de) 1989-10-12 1994-03-31 Imutran Ltd Modifiziertes biologisches material.
WO1993023085A1 (en) 1992-05-21 1993-11-25 Diatech, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
SE470006B (sv) 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
JP2000500121A (ja) 1995-09-27 2000-01-11 エモリー・ユニバーシティー 免疫系による生きた被移植細胞の破壊を阻止する方法
DE19623440A1 (de) * 1996-06-12 1997-12-18 Wagner Karl Heinz Dr Med Immobilisiertes organisches Material mit definiertem Wirkstoff-Release
JP4243355B2 (ja) 1997-03-26 2009-03-25 インペリアル カレッジ イノベイションズ リミテッド 細胞膜に固定された抗凝固性融合タンパク質

Also Published As

Publication number Publication date
ATE348149T1 (de) 2007-01-15
CA2361949C (en) 2010-08-03
EP1171156B1 (en) 2006-12-13
CA2361949A1 (en) 2000-08-10
AU769063B2 (en) 2004-01-15
AU2839900A (en) 2000-08-25
DE60032346D1 (en) 2007-01-25
SE523817C2 (sv) 2004-05-18
SE9900398D0 (sv) 1999-02-05
US7981873B1 (en) 2011-07-19
JP2003501346A (ja) 2003-01-14
WO2000045837A1 (en) 2000-08-10
EP1171156A1 (en) 2002-01-16
DE60032346T2 (de) 2007-07-19

Similar Documents

Publication Publication Date Title
MX2007004769A (es) Derivado de pirimidina condensado con un anillo no aromatico.
RU2490250C2 (ru) Спиросоединения и их фармацевтическое применение
WO2009023718A3 (en) Novel activators of glucokinase
CN105979975A (zh) 医疗敷料
SE9900398L (sv) Ny användning inom transplantationskirurgi
Liang et al. Lipid rescue of massive verapamil overdose: a case report
EP1454641A3 (en) Porous implantable medical device seeded with mammalian cells
BR9906813A (pt) Método para administração de insulina aspb28- humana
EP2762480A1 (en) Oxazolidinone antibiotics containing fused ring
RU2009110273A (ru) Способ уменьшения повреждения нервных клеток
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
NO20052505L (no) Ny bruk av dextran-sulfat
BR0306798A (pt) Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes.
Orban et al. Erythromycin-induced cardiac toxicity
CN115054601A (zh) 一种可注射的缓释镇痛复合物及其制备方法、应用
CA2593171A1 (en) Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
TR200200250T2 (tr) Glukoz alma agonistleri olarak yeni naftilsülfonik asitler, ilgili bileşikler
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
CO5611170A2 (es) Uso de un inhibidor antagonista contra el factor tisular
CN206434601U (zh) 一种新型辣椒碱水凝胶贴剂
KR20080061431A (ko) 에이디피-라이보실 사이클레이즈 억제제를 이용한 고혈압 및 당뇨병성 신증의 치료제
CN112209834A (zh) 一种有机亚硝酸根供体及其制备方法与医药用途
CN101474178A (zh) 盐酸戊乙奎醚在制备治疗心源性休克疾病药物中的应用
KR20170028566A (ko) 약물을 봉입한 이식 치료용 세포 클러스터 및 이의 제조방법
ATE451933T1 (de) Wirkstoff zur erhöhung der anzahl an dendritischen vorläuferzellen im blut

Legal Events

Date Code Title Description
NUG Patent has lapsed